Johnson Jennifer M
- SEC CIK
- 0001010270
No open-market purchases or sales filed in the past year.
Current role at each company
- BEN Franklin Templeton IncChief Executive Officeras of Sep 2, 2026
- TMO Thermo Fisher Scientific Inc.Directoras of Jun 30, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Johnson Jennifer M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BEN Franklin Templeton Inc
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 (view filing) | Aug 28 | 2 days | Johnson Jennifer MPresident and CEO | PPurchaseCommon Stock, par value $.10 | +12.7K | $19.66 | +$249.7K | +0.5%2.64M after | |
| Aug 26, 2024 (view filing) | Aug 23 | 3 days | Johnson Jennifer MPresident and CEO | PPurchaseCommon Stock, par value $.10 | +18.9K | $20.95 | +$396.0K | +9.5%216.9K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Johnson Jennifer MPresident and CEO | SSaleCommon Stock, par value $.10 | −55.2K | $28.75 | −$1.59M | −2.9%1.87M after | |
| Aug 19, 2021 (view filing) | Aug 19 | Same day | Johnson Jennifer MPresident and CEO | SSaleCommon Stock, par value $.10 | −52.8K | $30.37 | −$1.60M | −2.7%1.90M after |